CN101843712B - Chinese medicament for treating angina - Google Patents

Chinese medicament for treating angina Download PDF

Info

Publication number
CN101843712B
CN101843712B CN2009102358778A CN200910235877A CN101843712B CN 101843712 B CN101843712 B CN 101843712B CN 2009102358778 A CN2009102358778 A CN 2009102358778A CN 200910235877 A CN200910235877 A CN 200910235877A CN 101843712 B CN101843712 B CN 101843712B
Authority
CN
China
Prior art keywords
chinese medicine
parts
chinese
angelica
chinese medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102358778A
Other languages
Chinese (zh)
Other versions
CN101843712A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qinghai Qinghai Tibet Plateau Health Technology Co ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102358778A priority Critical patent/CN101843712B/en
Publication of CN101843712A publication Critical patent/CN101843712A/en
Application granted granted Critical
Publication of CN101843712B publication Critical patent/CN101843712B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating angina, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: rosewood heart wood, radix pseudo-ginseng, Chinese angelica, lucid ganoderma and root of rehmannia. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, and activating blood, dissolving stasis and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗心绞痛的中药Chinese medicine for treating angina pectoris

技术领域technical field

本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.

背景技术Background technique

现在的旨在治疗心绞痛的中药领域,存在着一些问题:一是效果不够明显,二是见效比较迟缓。以致于许多心绞痛患者长期受到胸闷胸痛的折磨,发生心肌梗死的几率增大,影响了生存质量。There are some problems in the field of traditional Chinese medicine aimed at treating angina pectoris: the first is that the effect is not obvious enough, and the second is that the effect is relatively slow. As a result, many patients with angina pectoris suffer from chest tightness and pain for a long time, and the probability of myocardial infarction increases, which affects the quality of life.

针对以上提出的问题,本发明提供一种治疗心绞痛的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for treating angina pectoris, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and the effect is relatively slow. The advantages.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗心绞痛的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of angina pectoris, adopts Chinese medicine raw material to prepare, and formula is (by weight):

降香3-20份    三七3-20份    当归4-30份Dalbergia 3-20 parts Sanqi 3-20 parts Angelica 4-30 parts

灵芝2-12份    生地4-30份Ganoderma lucidum 2-12 parts Rehmannia 4-30 parts

这种治疗心绞痛的中药是由下列方法制成的:This traditional Chinese medicine for treating angina pectoris is made by the following method:

(1)按上述重量比,将降香、当归、生地经常规水提取工艺提取,制成浸膏细粉;(1) according to the above-mentioned weight ratio, the extracts of Jiangxiang, Angelica, and Radix Rhizoma Rhizoma are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝、生地扶正培本,益气养血,养心安神,增强机体免疫力;当归、三七养血活血,化瘀止痛,扩张动脉,增加冠状动脉血流量;辅以降香温通行滞,化瘀通络止胸肋疼痛。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀止痛之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum and Shengdi Fuzheng Peiben can nourish qi and blood, nourish the heart and calm the nerves, and enhance the body's immunity; Angelica and Panax notoginseng nourish blood and activate blood, remove blood stasis and relieve pain, dilate arteries, and increase coronary blood flow; , Huayu dredging collaterals to relieve pain in the chest and ribs. All the medicines are compatible and complement each other, and they play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation, removing blood stasis and relieving pain. The effect is good, and the effect is fast.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

降香60克    三七60克    当归80克Dalbergia 60g Sanqi 60g Angelica 80g

灵芝40克    生地80克Ganoderma lucidum 40g Raw ground 80g

按规定重量,用常规水提取工艺将降香、当归、生地提取,制成浸膏细粉66克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊592粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract Jiangxiang, Angelica, and Rehmannia to make 66 grams of extract powder, grind Sanqi and Ganoderma lucidum into fine powder, mix with the above extract powder, stir evenly, and prepare into fine granules, put into No. 0 capsules, and make 592 Chinese medicine capsules, each capsule containing Chinese medicine fine powder and 0.28 grams of extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

降香100克     三七100克    当归160克Dalbergia 100g Sanqi 100g Angelica 160g

灵芝60克      生地160克Ganoderma lucidum 60g Raw ground 160g

按上述同样的方法,制成中药胶囊1021粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, 1021 Chinese medicine capsules were made, and each capsule contained Chinese medicine fine powder and 0.28 grams of extract.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

降香200克    三七200克    当归300克Dalbergia 200g Sanqi 200g Angelica 300g

灵芝120克    生地300克Ganoderma lucidum 120g Raw ground 300g

按上述同样的方法,制成中药胶囊2000粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, make 2000 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

降香6份    三七6份    当归8份6 parts of Jiangxiang 6 parts of Panax notoginseng 8 parts of Angelica

灵芝4份    生地8份Ganoderma lucidum 4 parts Rehmannia 8 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

降香12份   三七12份    当归20份12 parts of Jiangxiang 12 parts of Panax notoginseng 20 parts of Angelica

灵芝8份    生地20份Ganoderma lucidum 8 parts Rehmannia 20 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医心绞痛为例,经7例临床观察。选择中医诊断心绞痛为标准:胸闷胸痛,心慌心悸,四肢乏力,发作时心电图可见T波异常。如上症状,即可确诊。在确诊观察的对象中,男性4例,女性3例,无其它严重疾病,年龄为51岁-82岁,平均年龄66.4岁。The present invention takes angina pectoris of traditional Chinese medicine as an example, through clinical observation of 7 cases. Choose TCM diagnosis of angina pectoris as the standard: chest tightness and chest pain, palpitation and palpitation, limb weakness, abnormal T wave can be seen in the electrocardiogram during the attack. The above symptoms can be diagnosed. Among the objects under confirmed observation, there were 4 males and 3 females, without other serious diseases, aged 51-82 years, with an average age of 66.4 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,心区舒适,胸闷绞痛明显缓解或消失,心电图检查无异常。1. Significant effect: Physical fitness is enhanced, the heart area is comfortable, chest tightness and cramps are obviously relieved or disappeared, and the electrocardiogram is normal.

2、有效:体质有所增强,胸闷绞痛有所缓解。2. Effective: Physical fitness has been enhanced, and chest tightness and cramps have been relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的7人中,显效3人,有效3人,无效1人,总有效率85.7%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 7 people in the clinical trial, 3 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 85.7%.

Claims (1)

1.一种治疗心绞痛的中药,其特征在于,所述中药是采用中药原料制备,中药原料的重量配比为:1. a kind of Chinese medicine for the treatment of angina pectoris is characterized in that, described Chinese medicine is to adopt Chinese medicine raw material to prepare, and the weight proportion of Chinese medicine raw material is: 降香3——20份    三七3——20份    当归4——30份Dalbergia 3——20 parts Sanqi 3——20 parts Angelica 4——30 parts 灵芝2——12份    生地4——30份Ganoderma lucidum 2——12 parts Rehmannia 4——30 parts 这种治疗心绞痛的中药是由下列方法制成的:This traditional Chinese medicine for treating angina pectoris is made by the following method: (1)按上述重量比,将降香、当归、生地经常规水提取工艺提取,制成浸膏细粉;(1) according to the above-mentioned weight ratio, the extracts of Jiangxiang, Angelica, and Radix Rhizoma Rhizoma are extracted through a conventional water extraction process to make extract powder; (2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;制成中药颗粒剂、胶囊剂、水丸剂、片剂剂型。(2) Grind Sanqi and Ganoderma lucidum into fine powders according to the above weight ratio, mix with the above-mentioned extract powder, and stir evenly; make traditional Chinese medicine granules, capsules, water pills, and tablets.
CN2009102358778A 2009-10-28 2009-10-28 Chinese medicament for treating angina Expired - Fee Related CN101843712B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102358778A CN101843712B (en) 2009-10-28 2009-10-28 Chinese medicament for treating angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102358778A CN101843712B (en) 2009-10-28 2009-10-28 Chinese medicament for treating angina

Publications (2)

Publication Number Publication Date
CN101843712A CN101843712A (en) 2010-09-29
CN101843712B true CN101843712B (en) 2011-07-20

Family

ID=42768648

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102358778A Expired - Fee Related CN101843712B (en) 2009-10-28 2009-10-28 Chinese medicament for treating angina

Country Status (1)

Country Link
CN (1) CN101843712B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102379976A (en) * 2011-07-30 2012-03-21 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic heart disease
CN104367696A (en) * 2013-08-16 2015-02-25 黄雄强 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376491A (en) * 2002-04-15 2002-10-30 徐国勇 Medicine for treating myocardial infarction and angina pectoris

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376491A (en) * 2002-04-15 2002-10-30 徐国勇 Medicine for treating myocardial infarction and angina pectoris

Also Published As

Publication number Publication date
CN101843712A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843661B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843712A (en) Chinese medicament for treating angina
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843753B (en) Chinese medicament for treating angina
CN101843720B (en) Chinese medicament for treating angina
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843645B (en) Chinese medicament for treating tachycardia
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101396468B (en) A kind of traditional Chinese medicine for treating diabetic coronary heart disease
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101843831B (en) Chinese medicament for treating diabetic cardiopathy
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843792A (en) Chinese medicament for treating angina
CN101897808A (en) Chinese medicine for treating angina pectoris
CN101843646A (en) Chinese medicament for treating tachycardia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: QINGHAI-TIBET PLATEAU CHARACTERISTIC BIOLOGICAL RE

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20150504

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 810000 XINING, QINGHAI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150504

Address after: 810000 Qinghai biological science and Technology Industrial Park, Qinghai, Xining Province, No. two, No. 212, room 28

Patentee after: Qinghai Qinghai Tibet Plateau characteristic biological resources technology research and Development Co.,Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT Co.,Ltd.

CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 810699 building M1, No.1, South High Speed Rail Road, Pingxi Economic Zone, Haidong Industrial Park, Haidong District, Qinghai Province

Patentee after: Qinghai Qinghai-Tibet Plateau Health Technology Co.,Ltd.

Address before: 810000 Qinghai biological science and Technology Industrial Park, Qinghai, Xining Province, No. two, No. 212, room 28

Patentee before: Qinghai Qinghai Tibet Plateau characteristic biological resources technology research and Development Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110720

CF01 Termination of patent right due to non-payment of annual fee